HEALTHX Health X Platform (HEALTHX) Q4 FY26 results (Jan–Mar 2026) and concall
Health X Platform Limited reported a strong Q4 and FY26, marked by significant revenue and gross profit growth, and a substantial reduction in EBITDA and PAT losses. The company successfully transitioned to the HealthX identity, launched the JITO initiative for affordable healthcare, and continued to expand its B2B platform, Retailer Shakti. While operational metrics improved, Q4 PAT was impacted by non-operating factors. The company remains focused on technology-driven growth, capital efficiency, and strategic expansion of its warehousing capacity, targeting ₹6,000 crores revenue by FY2030.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue down 10.0%, net profit down 114.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 −9% | 0 −18% | 0 −10% |
| EBITDA | -0 | -0 | -0 | -0 | -0 +44% | -0 −48% | -0 +4% |
| Net profit | -0 | -0 | -0 | -0 | -0 +12% | -0 −310% | -0 −114% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
